These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1913679)

  • 1. Use and mechanism of action of AS101 in protecting bone marrow colony forming units-granulocyte-macrophage following purging with ASTA-Z 7557.
    Kalechman Y; Barkai IS; Albeck M; Horwith G; Sehagl SN; Sredni B
    Cancer Res; 1991 Oct; 51(20):5614-20. PubMed ID: 1913679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
    Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
    Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
    Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo synergistic effect of the immunomodulator AS101 and the PKC inducer bryostatin.
    Kalechman Y; Albeck M; Sredni B
    Cell Immunol; 1992 Aug; 143(1):143-53. PubMed ID: 1623562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of radioprotection conferred by the immunomodulator AS101.
    Kalechman Y; Gafter U; Barkai IS; Albeck M; Sredni B
    Exp Hematol; 1993 Jan; 21(1):150-5. PubMed ID: 8417951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E; Hervé P
    Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
    Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
    Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of murine late spleen colony-forming cells (day-12 CFU-S) and hematopoietic repopulating cells to mafosfamide (ASTA Z 7557).
    Kohn FR; Sladek NE
    Biochem Pharmacol; 1987 Sep; 36(17):2805-11. PubMed ID: 2820422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. I. Effects of in vitro culturing with IL-3 and GM-CSF on human and mouse bone marrow cells purged with mafosfamide (ASTA-Z).
    Slavin S; Mumcuoglu M; Landesberg-Weisz A; Kedar E
    Bone Marrow Transplant; 1989 Sep; 4(5):459-64. PubMed ID: 2676042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotective effects of the immunomodulator AS101.
    Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Seghal SN; Sredni B
    J Immunol; 1990 Sep; 145(5):1512-7. PubMed ID: 2384668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential differentiation of murine CFU-S toward granulopoiesis and megakaryocytopoiesis after in vitro incubation of bone marrow with ASTA-Z 7557.
    Sainteny F; Lopez M; Mary JY; Frindel E
    Exp Hematol; 1987 Jul; 15(6):631-5. PubMed ID: 3297759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased DNA repair ability after irradiation following treatment with the immunomodulator AS101.
    Kalechman Y; Shani A; Albeck M; Sotnik Barkai I; Sredni B
    Radiat Res; 1993 Nov; 136(2):197-204. PubMed ID: 8248476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective and restorative role of AS101 in combination with chemotherapy.
    Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Horwith G; Kirsch T; Maida B; Sehgal SN; Sredni B
    Cancer Res; 1991 Mar; 51(5):1499-503. PubMed ID: 1997189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
    Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
    Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of recombinant cytokines for enhancing immunohematopoietic reconstitution following bone marrow transplantation. II. The influence of lymphokines on CFU-GM colonies from human untreated, ASTA-Z or Campath-1M treated bone marrow.
    Mumcuoglu M; Naparstek E; Slavin S
    Bone Marrow Transplant; 1990 Mar; 5(3):153-8. PubMed ID: 2184907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP; Nikkels PG; Brockbank KG; Ploemacher RE; Voerman JS
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of AS101 on the reconstitution of T-cell reactivity following irradiation or cyclophosphamide treatment.
    Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
    Exp Hematol; 1992 Dec; 20(11):1302-8. PubMed ID: 1493859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of murine cytomegalovirus (MCMV) induced myelosuppression by AS101.
    Sredni B; Rosenthal-Galili Z; Michlin H; Sobelman D; Seger Y; Blagerman S; Kalechman Y; Rager-Zisman B
    Immunol Lett; 1994 Dec; 43(3):159-65. PubMed ID: 7721328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.